Abstract
Obesity became an epidemic public health problem and continuously increasing every year. For the longest time, the pathologic framework for obesity had been simple: caloric intake is greater than the energy output, which by far still true, however, the underlying reasons for increased energy intake and reduced energy expenditure remain largely unknown. Emerging data indicate that obesity can be oftentimes secondary to an underlying pathology, which can be due to genetics, inflammation, microbiome dysbiosis, metabolism, drugs and several other reasons. In this chapter, we described the pathology of obesity and underlying factors are linked or contributing in its progression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Schuffham PA (2017) Economic burden of obesity: a systemic literature review. Int J Environ Res Public Health 14(4):435
Preston SH, Andrew Stokes YCV (2018) The role of obesity in exceptionally slow US mortality improvement. Proc Natl Acad Sci USA 115(5):957–961
Segula D (2014) Complications of obesity in adults: a short review of the literature. Malawi Med J 25(1):20–24
Pandey R, Kumar N, Paroha S, Prasad R, Yadav M, Jain S, Yadav H (2013) Impact of obesity and diabetes on arthritis: an update. Health (Irvine California) 5(1):143–156
Hu FB, Li TY, Colditz GA et al (2003) Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 289(14): 1785–1791
Lee IM, Shiroma EJ, Lobelo F, Puska P, Balire SN et al (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. The Lancet 380(9838):219–229
Kac G, Pérez-Escamilla R (2013) Nutrition transition and obesity prevention through the life-course. Int J Obes Suppl 3:6–8
Yadav H, Rane SG (2015) Dietary fatty acids: friends or foes? obesity (Silver Spring) 23(7):1329
Hall KD, Ayuketah A, Brychta R, Cai H (2019) Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab 30(1):66–77
Geiker NR, Astrup A, Hjorth MF, Sjödin A, Pijls L, Markus CR (2018) Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes Rev 19(1):81–97
Rivenes AC, Harvey SB, Mykletun A (2009) The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study. J Psychosom Res 66(4):269–275
Morselli L, Leproult R, Balbo M, Spiegel K (2011) Role of sleep duration in the regulation of glucose metabolism and appetite. Best Pract Res Clin Endocrinol Metab 24(5):687–702
Spiegel K, Tasali E, Penev P, Van Cauter E (2004) Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141(11):846–850
Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA (2016) Obesity, inflammation, and cancer. Annu Rev Pathol: Mech Dis 11:421–449
Whang A, Nagpal R, Yadav H (2019) Bi-directional drug-microbiome interactions of anti-diabetics. The Lancet 39:591–602
Ley R (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26(1):5–11
Cox AJ, West NP, Cripps AW (2015) Obesity, inflammation, and the gut microbiota. The Lancet 3(3):207–215
Nagpal R, Newman TM, Wang S, Jain S, Lovato JF, Yadav H (2018) Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet. J Diab Res
Helene Choquet DM (2011) Genetics of obesity: what have we learned? Curr Genomics 12(3):169–179
Stavroula Paschou, H.M., Christos Mantzoros, Obesity: Genetics, Pathogenesis, Therapy. Principles of Diabetes Mellitus, 2015
Yadav H, Jain S (2016) Possible mystery behind higher susceptibility of type 2 diabetes in Asian Indians: is it diet, genetics or something else. J Nutr Health Food Eng 5
Rosenfield RL, Ehrmann DA (2016) The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37(5):467–520
Legro R (2012) Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med 30(6):496–506
Brothers KJ, Wu S, DiVall SA, Messmer MR, Kahn CR, Miller RS, Radovick S, Wondisford FE, Wolfe A (2010) Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor (IR). Cell Metab 12(3):295–305
Apovian C (2016) Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 22(7):176–185
Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P (2010) Screening for cushing’s syndrome in obese patients. Clinics (Sao Paulo) 65(1):9–13
Åsvold BO, Bjøro T, Vatten LJ (2009) Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab 94(12):1
WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1–253
Deurenberg P, Yap M, Van Staveren WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22(12):1164–1171
al, M.J.e., 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation, 2014. 129(25): p. 102–138
Jacobs EJ, Newton CC, Wang Y, Patel AV et al (2010) Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 170(15):1293–1301
Heymsfield SB, Wadden TA (2017) Mechanisms, pathophysiology, and management of obesity. N Eng J Med 376:254–266
Dietz WH, Baur LA, Hall K, Puhl RM, Taveras EM, Uauy R, Kopelman P (2015) Management of obesity: improvement of health-care training and systems for prevention and care. The Lancet 385(9986):20–26
Wadden TA, Butryn ML, Wilson C (2007) Lifestyle modification for the management of obesity. Gastroenterology 133(1):371
Brett EM (2018) Pharmacotherapy for weight management. Bariatr Endocrinol 395–411
Hollander PA, Elbein SC, Hirsch IB, Kelley D (1998) Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study. Diab Care 21(8):1288–1294
Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR, Anderson CM (2011) A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab 96(10):3066–3077
Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, Aronne L (2013) Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes 37:1443–1451
Peterli R, Wölnerhanssen BK, Peters T et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity. JAMA 319(3):255–265
Dogan K, Gadiot RP, Aarts EO, Betzel B, van Laarhoven CJ, Biter LU et al (2015) Effectiveness and safety of sleeve gastrectomy, gastric bypass, and adjustable gastric banding in morbidly obese patients: a multicenter, retrospective, matched cohort study. Obes Surg 25(7):1110–1118
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
So, I., Yadav, H. (2020). Obesity and Its Complications Pathogenesis. In: Tappia, P., Ramjiawan, B., Dhalla, N. (eds) Pathophysiology of Obesity-Induced Health Complications. Advances in Biochemistry in Health and Disease, vol 19. Springer, Cham. https://doi.org/10.1007/978-3-030-35358-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-35358-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35357-5
Online ISBN: 978-3-030-35358-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)